Close

Clinical Trials

AIVITA Biomedical completes patient enrollment target in phase 2 GBM trial for glioblastoma

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, announced that it has reached its patient enrollment target in the company's...

Sanofis phase 2 study of BTK inhibitor, SAR442168 meets primary endpoint to treat MS

The Sanofi phase 2b study evaluating its investigational BTK (Brutons tyrosine kinase) inhibitor (SAR442168), an oral, brain-penetrant, selective small molecule, achieved its primary endpoint. In...

Teva Announces Positive Top-Line Results from AJOVY Clinical Trials in Japan

Teva Pharmaceutical Industries Ltd announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development in...

NeuroSense initiates clinical studies to evaluate benefit of PrimeC for ALS patients

NeuroSense Therapeutics, a biotech company developing PrimeC, a combination drug which aims to slow or halt ALS progression, announced the initiation of two clinical...

Sharp Clinical broadens global client support with Business Development appointments

Sharp Clinical Services, a part of UDG Healthcare and a leading provider of global clinical supply services, has added three key members to its...

Elsevier creates free information center to bring together latest clinical research on novel coronavirus 2019-nCoV

For the benefit of healthcare professionals, medical researchers and the public, Elsevier, a global information analytics business specializing in science and health, has created...

Inceptua appoints new Head of Asia-Pacific, Clinical Trial Services

Inceptua announced that Paul Wituschek has been appointed President North America. To further strengthen its position as a leading pharmaceutical company and service partner,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read